Katherine May, the best-selling author, has one simple question to help you get started.
Category: Mental Health and Disorders
-
How Parenting Today Is Different, and Harder
The New York Times – Fashion & Style:In many ways, it’s more demanding than before. But according to a new survey, parents feel pressure to be more emotionally hands-on.
-
How a Pre-Wedding Diet Led to an Eating Disorder
The New York Times – Fashion & Style:One bride talks about how the desire to lose weight quickly spiraled out of control.
-
Should You Quit Your Job?
The New York Times – Business:Jacinda Ardern stepped away from her role because she no longer has “enough in the tank” to do it. If you relate, here’s what to consider.
-
Regulators Announce Changes to Nursing Home Rating System
The New York Times – Business:The federal agency that oversees nursing homes has tightened rules around the use of powerful antipsychotic drugs.
-
I Chose to Compete as My True, Trans Self. I Win Less, but I Live More.
The New York Times – Sports:It might not seem like such a big deal to swim on a team that doesn’t align with your true self, but I was struggling to get out of bed for practice.
-
Legal Use of Hallucinogenic Mushrooms Begins in Oregon
The New York Times – Business:On Jan. 1, Oregon became the first state to allow adult use of psilocybin “magic” mushrooms. Licensed guides will likely determine whether the program is a success.
-
From the DealBook Summit: Leaders Look Into the Future
The New York Times – Business:Groundbreakers at the conference were asked what’s coming next for the brain, climate, medicine, labor, security and business.
-
Female College Athletes Say Pressure to Cut Body Fat Is Toxic
The New York Times – Sports:Several women in track and field said their mental health spiraled as they skipped meals to be leaner at the urging of coaches and peers.
-
With Promise of Legalization, Psychedelic Companies Joust Over Future Profits
The New York Times – Business:Cash rich start-ups are filing scores of patent claims on hallucinogens like magic mushrooms. Researchers and patient advocates worry high prices will make the therapies unaffordable.